Effects of atorvastatin on fasting plasma and marginated apolipoproteins B48 and B100 in large, triglyceride-rich lipoproteins in familial combined hyperlipidemia

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 10, 2004, Pages 5021-5029

  Verseyden, C ^a,c   Meijssen, S ^a   Castro Cabezas, M ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SINT FRANCISCUS GASTHUIS   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; ATORVASTATIN; CHYLOMICRON; FLUINDOSTATIN; INTRALIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; FAMILIAL COMBINED HYPERLIPIDEMIA; FAMILIAL DISEASE; HUMAN; HYPERLIPIDEMIA; MEASUREMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; CHOLESTEROL; FASTING; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; MALE; MIDDLE AGED; PYRROLES; TRIGLYCERIDES;

EID: 6344254568     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032171     Document Type: Article

References (46)

1. Kim E, Young SG 1998 Genetically modified mice for the study of apolipoprotein B. J Lipid Res 39:703-723
2. Young SG 1990 Recent progress in understanding apolipoprotein B. Circulation 82:1574-1594
3. Elovson J, Chatterton JE, Bell GT, Schumaker VN, Reuben MA, Puppione DL, Reeve Jr JR, Young NL 1988 Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res 29:1461-1473
4. Cohn JS, Johnson EJ, Millar JS, Cohn SD, Milne RW, Marcel YL, Russell RM, Schaefer EJ 1993 Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 34:2033-2040
5. Karpe F, Hamsten A 1994 Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res 35:1311-1317
6. Verseyden C, Meijssen S, Castro Cabezas M 2002 Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia. J Lipid Res 43:274-280
7. Brown MS, Goldstein JL 1983 Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J Clin Invest 72:743-747
8. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK 1988 Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 7:4119-4127
9. 2-macroglobulin receptor. J Biol Chem 266:13936-13940
10. Febbraio M, Hajjar DP, Silverstein RL 2001 CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108:785-791
11. Niemeier A, Gafvels M, Heeren J, Meyer N, Angelin B, Beisiegel U 1996 VLDL receptor mediates the uptake of human chylomicron remnants in vitro. J Lipid Res 37:1733-1742
12. van Vlijmen BJ, Rohlmann A, Page ST, Bensadoun A, Bos IS, van Berkel TJ, Havekes LM, Herz J 1999 An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins. J Biol Chem 274:35219-35226
13. Eisenberg S, Sehayek E, Olivecrona T, Vlodavsky I 1992 Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J Clin Invest 90:2013-2021
14. Hussain MM, Goldberg IJ, Weisgraber KH, Mahley RW, Innerarity TL 1997 Uptake of chylomicrons by the liver, but not by the bone marrow, is modulated by lipoprotein lipase activity. Arterioscler Thromb Vasc Biol 17:1407-1413
15. van Bennekum AM, Kako Y, Weinstock PH, Harrison EH, Deckelbaum RJ, Goldberg IJ, Blaner WS 1999 Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester. J Lipid Res 40:565-574
16. Karpe F, Olivecrona T, Walldius G, Hamsten A 1992 Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. J Lipid Res 33:975-984
17. Peterson J, Bihain BE, Bengtsson-Olivecrona G, Deckelbaum RJ, Carpentier YA, Olivecrona T 1990 Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc Natl Acad Sci USA 87:909-913
18. Hultin M, Savonen R, Olivecrona T 1996 Chylomicron metabolism in rats: lipolysis, recirculation of triglyceride-derived fatty acids in plasma FFA, and fate of core lipids as analyzed by compartmental modelling. J Lipid Res 37:1022-1036
19. Karpe F, Olivecrona T, Hamsten A, Hultin M 1997 Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants. J Lipid Res 38: 949-961
20. Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J 2002 Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417:750-754
21. Castro Cabezas M, de Bruin TW, Jansen H, Kock LA, Kortlandt W, Erkelens DW 1993 Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler Thromb 13:804-814
22. Chait A, Albers JJ, Brunzell JD 1980 Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia. Eur J Clin Invest 10:17-22
23. Venkatesan S, Cullen P, Pacy P, Halliday D, Scott J 1993 Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb 13:1110-1118
24. Krebs M, Stingl H, Nowotny P, Weghuber D, Bischof M, Waldhausl W, Roden M 2000 Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin Chem 46:950-954
25. Burstein M, Scholnick HR, Morfin R 1970 Rapid method for the isolation of tipoproteins from human serum by precipitation with polyanions. J Lipid Res 11:583-595
26. Guerin M, Lassel TS, Le Goff W, Farnier M, Chapman MJ 2000 Action of atorvastatin in combined hyperlipidemia. Preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles. Arterioscler Thromb Vasc Biol 20:189-197
27. Mullick AR, Deckelbaum RJ, Goldberg IJ, Al-Haideri M, Rutledge JC 2002 Apolipoprotein E and lipoprotein lipase increase triglyceride-rich particle binding but decrease particle penetration in arterial wall. Arterioscler Thromb Vasc Biol 22:2080-2085
28. Rensen PCN, Herijgers N, Netscher MN, Meskers SCJ, van Eck M, van Berkel ThJC 1997 Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J Lipid Res 38:1070-1084
29. Erkelens DW, Brunzell JD, Bierman EL 1979 Availablity of apolipoprotein CII in relation to the maximal removal capacity for an infused triglyceride emulsion in man. Metabolism 28:495-501
30. Bjorkegren J, Packard CJ, Hamsten A, Bedford D, Caslake M, Foster L, Shepherd J, Stewart P, Karpe F 1996 Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 37:76-86
31. Brunzell JD, Hazzard WR, Porte DJ, Bierman EL 1973 Evidence for a common saturable, triglycerie removal mechanism fro chylomicrons and very low density lipoproteins in man. J Clin Invest 52:1578-1585
32. Castro Cabezas M, Erkelens DW, Kock LA, de Bruin TW 1994 Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides. Eur J Clin Invest 24:669-678
33. Cortner JA, Coates PM, Bennett MJ, Cryer DR, Le NA 1991 Familial combined hyperlipidaemia: use of stable isotopes to demonstrate overproduction of very low-density lipoprotein apolipoprotein B by the liver. J Inherit Metab Dis 14:915-922
34. Verseyden C, Meijssen S, van Dijk H, Jansen H, Castro Cabezas M 2003 Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia. J Lipid Res 44:2100-2108
35. Karpe F, Hultin M 1995 Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway. J Lipid Res 36:1557-1566
36. van Wijk JP, van Oostrom AJ, Castro Cabezas M 2003 Normal ranges of non-fasting triglycerides in healthy Dutch males and females. Clin Chim Acta 1-2:49-57
37. Naoumova RP, Marais AD, Mountney J, Firth JC, Rendell NB, Taylor GW, Thompson GR 1996 Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia. Atherosclerosis 119:203-213
38. Morikawa S, Umetani M, Nakagawa S, Yamazaki H, Suganami H, Inoue K, Kitahara M, Hamakubo T, Kodama T, Saito Y 2000 Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells. J Atheroscler Thromb 7:138-144
39. Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JA, Seman LJ, Ferrari A, Rubenstein JJ 2002 Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. Am J Cardiol 90:689-696
40. Cohn JS, Tremblay M, Batal R, Jacques H, Veilleux L, Rodriquez C, Barrett PHR, Dubreuil D, Roy M, Bernier L, Mamer O, Davignon J 2002 Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia. J Lipid Res 43:1464-1471
41. Parhofer KGH, Laubach E, Barrett PHR 2003 Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients. J Lipid Res 44:1192-1198
42. Malhotra HS, Goa KL 2001 Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia. Drugs 61:1835-1881
43. van Barlingen HH, de Jong H, Erkelens DW, de Bruin TW 1996 Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: modulation by apolipoprotein E and apolipoprotein C. J Lipid Res 37:754-763
44. Pentikainen MO, Oksjoki R, Oonti K, Kovanen PT 2002 Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more. Arterioscler Thromb Vasc Biol 22:211-217
45. Olivecrona G, Olivecrona T 1998 Clearance of artificial triacylglycerol particles. Curr Opin Clin Nutr Metab Care 1:143-151
46. Williams KJ, Tabas I 1995 The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15:551-561